NCT06038318Recruiting
Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
Source: ClinicalTrials.gov · Last updated 29 Dec 2025
Brief summary (registry, in English)
The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce back" or be resilient after a difficult situation. Participants will take part in the "Promoting Resilience in Stress Management" PRISM program, which is designed to provide skills to change or improve the impact of stress in everyday life. The name of the intervention used in this research study is: -PRISM (a mobile app program comprised of 6 sessions of skills-based, manualized resilience education)
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 325 (estimated)
- First submitted
- 8 Sept 2023
- Start date
- 16 Oct 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Dana-Farber Cancer Institute
- Diseases
- Childhood cancers
- NCT number
- NCT06038318
What you commit to
- Study type: Interventional
- Planned participants: 325
- From 16 Oct 2023 to the primary completion date, 31 Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- All genders ≥ 12 and ≤ 25 years of age at baseline
- Participant is able to speak English or Spanish language (for PRISM sessions)
- Participant is able to read English or Spanish language (for completion of surveys)
- Participant is cognitively able to participate in PRISM sessions and complete written questionnaires and surveys, as judged by the site investigator
Criteria the registry did not label
- Participants that have completed their main cancer-directed therapy at one of the study sites affiliated centers who meet all the eligibility criteria will be eligible for participation in this study.
Age in the registry: 12 years to 25 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
| Boston Children's Hospital Coordinator of this site? Confirm its status | Boston | United States | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.